MiR-223 or miR-126 predicts resistance to dual antiplatelet therapy in patients with ST-elevation myocardial infarction

OBJECTIVE: To explore the role of miR-223 and miR-126 in predicting treatment responses to dual antiplatelet therapy (DAPT) in patients with ST-elevation myocardial infarction (STEMI). METHODS: Plasma miR-223 and miR-126 levels were measured before treatment. Treatment responses and 2-year survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaojing, Yao, Qi, Cui, Hanbin, Yang, Jun, Wu, Nan, Liu, Yahui, Zhou, Ying, Zhang, Yinwei, Su, Jia, Xia, Yezi, Chen, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191085/
https://www.ncbi.nlm.nih.gov/pubmed/34098766
http://dx.doi.org/10.1177/03000605211016209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191085/
https://www.ncbi.nlm.nih.gov/pubmed/34098766
http://dx.doi.org/10.1177/03000605211016209

Ejemplares similares